Home›Companies›Biotech & Pharma›Majesty Therapeutics

Majesty Therapeutics, Inc.

Works on targeted biology for vascular and fibrotic diseases.

Updated Nov 10, 2026·Latest SEC filing May 15, 2026·Suggest an edit

About Majesty Therapeutics

Majesty Therapeutics is a private company based in Sea Ranch Lakes, Florida, incorporated in 2024 in Delaware. It has reported $100,000 raised in one offering on Form D since May 2026. Its chief executive is Shawn Titcomb.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 1, 2026May 15, 2026$100,000of $5.0M target3$33,333Securities on exercise, SAFERule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Majesty Therapeutics's Form D filed May 15, 2026.

ST
Shawn Titcomb
Chief Executive Officer and director
Also a director at Praesidia Biotherapeutics.
AH
Adrian Hepner
Acting Chief Medical Officer
AB
Ankit Bhargava
Acting Chief Scientific Officer

Sources

  1. SECMajesty Therapeutics, Inc. filing history